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Human placentation is mediated by fetal trophoblastic ells which penetrate into the decidualized uterine endometrium. 
Trophoblast invasion requires the precisely regulated secretion of specific proteinases able to degrade the endometrial basement 
membranes and extracellular matrix. To document further the involvement of these proteinases during human placentation, we 
evaluated in vivo the expression of stromelysin-3, a member of the metalloproteinase family, during the first and third trimesters 
of pregnancy, by means of immunohistochemistry, in situ hybridization and Northern blot analysis. Human extravillous 
trophoblasts invading the maternal decidua produced stromelysin-3 during both, the first and third trimesters of pregnancy, but 
to a lesser extent during the latter. In floating villi, stromelysin-3 expression was restricted to the syncytiotrophoblasts that line 
intervillous vascular spaces. In conclusion, stromelysin-3 is expressed by differentiated, non-proliferative illous and extravillous 
trophoblastic cells in early and late placental beds and villi, and its pattern of expression evolves during pregnancy. Our 
observations suggest hat stromelysin-3 could play a role in human placentation. © 1997 W. B. Saunders Company Ltd 
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INTRODUCTION 
Implantation of the human blastocyst and the subsequent 
placental development are dependent on trophoblast invasion 
of the decidualized endometrium. As implantation proceeds, 
undifferentiated villous cytotrophoblast em cells (CTB) 
originating from the outer cell layer of the blastocyst divide 
and differentiate into morphologically and functionally distinct 
cell populations. In the villi, they fuse to form hormonally 
active villous syncytiotrophoblast (STB) which controls the 
transfer of solutes between maternal and fetal blood. Where 
villi contact the uterine wall, multilayered trophoblast cell 
columns (TCC) physically anchor the embryo to the decidua. 
In these columns, CTB differentiate progressively into non- 
proliferative, invasive and migratory intermediate rophoblasts 
(IT) (Damsky et al., 1992; Kliman and Feinberg, 1992; 
Damsky, Sutherland and Fisher, 1993). During the first 
4 months of gestation [Figure l(a)], these IT sprout from the 
TCC and migrate through the decidua nd the inner third of 
the myometrium. They infiltrate the walls of the spiral arteries 
and replace the endothelial lining as far as the myometrial 
segment of the vessels. This invasive trophoblastic activity 
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is characterized by the breaching of multiple basement 
membranes (including those of the endometrial g ands, blood 
vessels and decidual cells) and the degradation of the inter- 
stitial extracellular matrix (ECM) of the decidua (Boyd and 
Hamilton, 1967; Brosens, Robertson and Dixon, 1967; 
Pijnenborg et al., 1980; Tuttel et al., 1985; Aplin, 1991; 
Foidart et al., 1992). 
The human placenta thus functions as an invasive tissue, 
analogous to a locally invasive tumour (Liotta, 1986). How- 
ever, unlike tumour invasion, trophoblast penetration is 
regulated precisely, both spatially and temporally, during 
gestation. 
Several in vitro and in vivo studies have revealed that 
trophoblast cells have a regulated capacity to produce different 
matrix-degrading enzymes (Lala and Graham, 1990; Bischof 
and Martelli, 1992; Graham and Lala, 1992). Production of 
serine proteinases, uch as urokinase-type plasminogen acti- 
vator (u-PA) by trophoblastic cells correlates temporally with 
blastocyst invasion (Sherman, Strickland and Reich, 1976; 
Strickland, Reich and Sherman, 1976; Sappino et al., 1989; 
Behrendtsen, Alexander and Werb, 1992). The presence 
of u-PA, plasminogen activator inhibitor type 1 and u-PA 
receptor has been associated with infiltrating trophoblasts 
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Figure 1. Localization of ST3 in a first trimester (11 weeks) placental bed. (A) Diagram showing the spatial organization of the fetal-maternal interface at the 
end of the first trimester. D, decidua; CTB, cytotrophoblast; IT, intermediate rophoblast; IVC, intervillous chamber; IVT, intravascular trophoblast; MBV, 
maternal blood vessel; PBGC, placental-bed giant cell; S, stroma; STB, s.vncytiotrophoblast bordered by sinusoids; TCC, trophoblastic cell column. (B) Transverse 
section througb a villus showing STB strongly labelled by the anti-ST3 antibody. Scale bar=10l) p.m. (C) Longitudinal section through the placental bed. Strong 
STB positivity (arrows) for ST3 is observed. ST3 is also expressed by some spindle-shaped IT (arrowheads) that are derived from negative TCC, become detached 
and infiltrate the maternal decidua. Scale bar=lS0 lam. (D) Deeper in the decidua, numerous elongated IT, interspersed among negative decidual ce ls, were 
recognized by the anti-ST3 antibody. Scale bar=200 ~tm. (El Some IT fused to form PBGC which also express ST3. Scale bar=15(I p-m. (17)The endothelial lining 
of the maternal blood vessels has been replaced by ST3-positive trophohlasts. Scale bar=8ll ~lm. 
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(Feinberg et al., 1989; Zini et al., 1992; Hoffman et al., 1994). 
Members of the matrix metalloproteinases (MMP) family also 
appear to play a pivotal role during placentation. The acqui- 
sition of an invasive phenotype by early trophoblasts has been 
correlated with the ability of these cells to synthesize a large 
array of MMP: interstitial collagenase (Yagel et al., 1988; Moll 
and Lane, 1990), gelatinase A (Bischof et al., 1991; Autio- 
Harmeinen et al., 1992; Fernandez et al., 1992; Blankenship 
and King, 1994; Polette t al., 1994), gelatinase B (Fisher et al., 
1985; Emonard et al., 1990; Bischof et al., 1991; Librach 
et al., 1991; Behrendtsen, Alexander and Werb, 1992; 
Emonard et al., 1993; Polette et al., 1994), stromelysin-1 and 
stromelysin-2 (Brenner et al., 1989), as well as a membrane- 
type MMP potentially involved in gelatinase A activation 
(Nawrocki et al., 1996). The invasive trophoblasts and the 
maternal decidual cells also secrete specific inhibitors of 
these proteinases: plasminogen-activator inhibitors 1 and 2 
(Feinberg et al., 1989; Hofmann et al., 1994), and tissue 
inhibitors of metalloproteinases 1 and 2 (Lala, and Graham, 
1990; Polette et al., 1994). Thus, trophoblast invasiveness 
appears to be regulated tightly by the balance between the 
activated enzymes and their inhibitors. 
A few years ago, another member of the MMP family, 
stromelysin-3 (ST3), was identified (Basset, Wolf and 
Chambon, 1990). ST3 exhibits the same general features as 
previously described MMP, including a typical zinc-binding 
site and a conserved cysteine residue characteristic of the 
MMP prodomain (Basset, Wolf and Chambon, 1993). 
Although its physiological substrate is still unknown, ST3 is 
probably a proteinase, because the purified protein exhibits 
proteolytic activities (Murphy et al., 1993). However, ST3 
displays functional properties and an activation mechanism 
different from that of other MMP (Birkedal-Hansen et al., 
1993; Murphy et al., 1993; Pei, Majmudar and Weiss, 1994; 
NoEl et al., 1995; Santavicca et al., 1996). Wolf and co-workers 
demonstrated that st3 transcription i  embryonic fibroblasts 
can be induced by 12-o-tetradecanoyl phorbol 13-acetate and 
growth factors, thereby suggesting a transcriptional regulation 
similar to that of interstitial collagenase, stromelysin-1 and 
gelatinase B (Wolf et al., 1992). According to those data, ST3 
appears to belong to a new MMP subfamily that exhibits 
its proper enzymatic characteristics and narrow substrate 
specificity (Basset et al., 1993; Murphy et al., 1993; Pei, 
Majmudar and Weiss, 1994; Noel et al., 1995). The st3 gene 
is known to be expressed in the stromal compartment of 
most invasive human carcinomas and the highest levels of 
ST3 transcripts are found in tumours demonstrating high 
local invasiveness (Urbanski et al., 1992; Wolf et al., 1992; 
Basset, Wolf and Chambon, 1993; Birkedal-Hansen et al., 
1993; H~ihnel et al., 1993; Kawami et al., 1993; Muller et al., 
1993; Polette et al., 1993; Segain et al., 1993). However, 
ST3 transcripts are also present in healthy situations in 
which extensive ECM remodelling occurs: embryonic devel- 
opment (Basset et al., 1990), frog metamorphosis (Patterson, 
Par Hayes and Shi, 1995), mammary gland involution 
(Lefebvre et al., 1992), normal uterus and, interestingly, at 
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very high levels in human term placenta (Basset et al., 
1990). 
To localize ST3 in placental tissues and to investigate the 
potential role of this enzyme during human placentation, 
immunohistochemical l belling, in situ hybridization and 
Northern blot analysis were used to evaluate the expression of 
ST3 in first and third trimester placental tissues from normal 
pregnancies. 
MATERIALS AND METHODS 
Tissue preparation 
Samples of human placental villi obtained from 16 first 
trimester therapeutic abortions and 10 term third trimester 
placentae immediately after delivery were examined. Twelve 
placental-bed biopsies were obtained in situ with echoguided 
sampling forceps during the first and third trimesters of 
normal pregnancies. This procedure allows precise anatomical 
localization (placental bed) of the sample and prevents the 
tissue disruption observed uring abortion or delivery (Hustin 
and Franchimont, 1992). Finally, four full-thickness implan- 
tation sites in hysterectomy specimens taken at 8.5-13 weeks 
of pregnancy were also studied. One part of each sample 
was frozen in liquid nitrogen for Northern blot analysis, 
while the remainder was fixed in formalin and embedded in 
paraffin for in situ hybridization and immunohistochemical 
studies. 
Immunohistochemistry 
Immunolabelling of ST3 was accomplished according to the 
following procedure. Endogenous peroxidase activity was 
quenched by a 10-min incubation with 3 per cent hydrogen 
peroxide in phosphate-buffered saline (PBS). Tissues sections 
were subjected to three 5-min heating cycles in citric acid 
buffer (pH 6) in a microwave oven (Philips, power setting: 
750 W). Non-specific antibody binding was blocked by 
incubation in 7 per cent bovine serum albumin-PBS (BSA- 
PBS) for 30 min. Sections were incubated overnight at room 
temperature with a mouse monoclonal ntibody raised against 
the haemopexin domain of ST3 (5ST-4A9) (Wolf et al., 1993; 
Santavicca et al., 1995), grown as an ascites fluid and used 
diluted 1/4000 in 3 per cent BSA-PBS. A biotinylated second- 
ary antibody (LSAB 2 Kit, Dako, Denmark) was applied for 
30min prior to incubation with streptavidin-horseradish 
peroxidase (LSAB 2 Kit) for an additional 30 rain. Antibody 
localization was visualized with a solution of diaminobenzidine 
and 0.03 per cent hydrogen peroxide. Each step of the 
procedure was followed by three washes in PBS. 
To evaluate the specificity of immunolabelling, the primary 
antibody was replaced by either an ascites fluid containing 
5ST-4A9 which was preincubated with immobilized recom- 
binant ST3 (Santavicca et al., 1995) or an isotype-matched 
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Figure 2. l,ocalization of ST3 mRNA in first trimester ~illi and placental beds. (A) mRNA transcripts ofST3 are detected in the S'I'B (arrmvheads) of~illi. The 
decidua (1)) does not express ST3. Scale bar=200 ~.tm. (B) "I'(X: arising from Ihc villus do nm c(mtain ST3 mRNA while the STB (arrmvheads) is clearly labelled. 
Scale bar=l()0 )_tin. (C) ['|" (arrowheads) expressing S'1'3 mRNA have replaced the ndothelial lining of .\II3V. Scale bar=50 lain. (I)) A seeti(m incubated ~itll die 
sense RNA pr()bc. Scale har=2()(lFtm. (1':) IT (arnmhcads) expressing S'F3 mRNA are obser',ed among decidual cells. Scale bar=25).tin. 
irrelevant antibody (a mouse ascitcs fluid raised against 
hamster CD-3). No immunoreact iv i ty was observed in the 
controls. 
Epithelial cells and t,'ophoblasts were identified by immuno-  
histochemical labelling with a mtmochmal antibody to cvto- 
kcm'atins 8 /18 (CAM 5.2, Becton- l ) ick inson) revealed with a 
rabbit ant i -mouse antibody conjugated to horseradish peroxi- 
dasc (1/50 in PBS; Dako). All sections were counterstained 
with hematox.vlin, mounted,  and examined under an OI.vmpus 
AH3 microscope. 
In situ hybridization 
Paraftin was removed from 5-).ml thick tissue sections whicb 
were then rehvdratcd and treated with 0.2 M HCI for 20 min at 
room temperature,  fi)llowed by a 15-min incubation at 37°(i 
with proteinase K (1 I.tg/ml in Tr is-ethvlcnediaminetet l 'aacet ic 
acid-NaCl;  Sigma Chemical Co., St l,ouis, MO,  USA)  to 
remove basic proteins. The  sections were washed in 2 x SSC 
(sal ine-sodium citrate), acetvlated in 0.25 per cent acetic 
anhvdr idc in 0.1 M tr icthanolamine for 10 min and hybridized 
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Figure 3. Term placental hod. (:\) Immunolahclling of cytokcratins t'c~ cak'd thdr presence h'~ S'FB, a t'L'~ CTIL TCC (arrmvs) and IT. Scale har=150 vml. (B) 
The S'l'13 and a suhpopulation f the IT in this serial section reacted poshivcl.v ~ith the anri-NT3 antflmd~. The 'I'(X~ arc negative (arums). Scale har=l 5(1 [am. 
overnight with SsS-labellcd antisense RNA t,anscripts. ST3 
eDNA insert (160()-bp Z IV probe; Basset et al., 1993) was 
subcloncd into the Blt, escript plasmid (Stratagene, l a Jolla, 
CA, USA) and used to prcpare ~sS-lahcllcd RNA probes. 
Hybridizations were followed by RNase treatment (20 l.tg/ml, 
111, 37°(") to remove unhvbridizcd probes. Four stringent 
washes (2 x SSC and 1 x SSC, 15 rain at room temperature) 
were performed and autoradiography was carried out by using 
1)19 emulsion (Kodak, Vilvorde, Belgium). Slides were 
exposed fi)r 21 days prior to development. The controls 
were performed under the same cnnditions using ~SS-labelled 
sense RNA probes. All slides were countcrstained with haema- 
toxylin, mountcd and examined under an Olympus AH3 
microscope. Control slides were negative. 
Northern blot analysis 
Total RNA was extracted fl'om tissues by RNAzol treatment 
(Biogenesis, Bournemouth, UK). An aliquot of RNA (15 l J-g) 
was electrophorescd on 1 per ccnt agarnsc gels, containing 10 
per cent formaldehyde and t,'ansfcrrcd onto a nylon membrane 
(Hybond"%N; Amersham, Gent, Belgium). The membrane 
was hybridized with a cDNA probe (as described above), that 
had been labelled with .;2p using randonl priming synthesis 
(Bochringcr .Xlannheim, Mannheim, Germany). The filter was 
exposed for 1 day for floating villi and 7 days for placental beds 
(six independent samples were analysed for each gestational 
stage). The membrane was rehvbridized to an oligonuclcotide 
probe of human 28 S rRNA (Chmcth, Palo Alto, CA, USA), 
which served as a control. The amounts of ST3 transcripts 
were quantified by densitometric analysis ofautoradiographs of 
the Northern blots. All results were corrected for RNA loading 
by dcnsitometric data obtained for the 28 S rRNA signals. 
RESULTS 
Immunolabelling of the first trimes'ter placental-bed biopsies 
and implantation-site s ctions with anti-cvtokeratin antibody 
revealed mainly two  different trophoblastic populations: the 
anchoring TCC (composed of rounded unitm'nl cohesive cells) 
that sprouted from the base of the villi and penetrated into the 
decidua; and |usitbrm I'1" that rose fi'om the tips of the TCC 
and infiltrated the placental bed as deep as the mw)mctrium. 
Some of these IT were located in the maternal arterial walls 
anti lumen as intravascular trophoblasts (IVT), while others 
fused with each other to form multinucleated placental-bed 
giant cells (PBGC) (Loke, 1990). \\;hen sections were incu- 
bated with anti-ST3 antibody, the villous C'I'B anti their 
developing TCC anchors were t, nreactive. In cont,'ast, clearly 
positive IT and PBGC were interspersed among negative 
decidual cells throughout the placental-bed thickness [Figure 
I(C), (D) and (E)]. In some maternal blood vessels, the 
endothelial lining" had been replaced by ST3-positive trnpho- 
blasts [Figure I(F)]. Deeper in the myometrium, very few 
ST3-positivc trophoblastic ells were observed (data not 
shown). 
In situ hybridization data clearly indicated that ST3 mRNA 
was localized in the same immunoreactive cell populations 
(i.e. IT, PBGC and IVT) in the first trimester placental beds 
(Figure 2). 
Anahsis of first trimester floating villi by both immuno- 
histochemistrv anti in situ hybridization revealed that the STB 
layer, which borders the villous surface, was strongly positive 
f'or ST3 protein and mRNA transcripts. In contrast, no 
detectable label was observed in the underlying villous CTB or 
in the stromal core (including the fetal fibroblasts, Hotbauer's 
cells and vascular endothelial cells) [(Figures I(B) and 2(A)]. 
As gestation progresses, placental morphology changes. In 
floating villi, the vilhms SUl'fhce xpands and the CTB become 
widely separated. When term floating villi were examined, only 
STB were positive for ST3; CTB and the stromal core were 
negative [Figure 3(B)]. These findings were confirmed by 
hybridization studies (data not shown). Ii1 term placental beds, 
the TCC had fi'equcntly lost their structure anti were limited 
to a few cell layers. Their precise delimitation required 
cvtokeratin imnmnolabelling [Figure 3(A)]. As illustrated 
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in Figure 3(B), the TCC were negative for ST3. In the 
decidua, cytokeratin-positive IT were present [Figure 3(A)] 
but they had assumed a more rounded shape than during the 
first trimester, an observation that reflects their diminished 
migratory capacity. Immunolabelling of the third trimester 
placental beds did not reveal any significant modification in the 
expression pattern of ST3. No immunoreactivity was observed 
in TCC, while positivity was only seen in IT  [Figure 3(B)]. 
ST3 mRNA localization was restricted to IT  (data not shown). 
These histological studies were complemented by Northern 
blot analysis in order to obtain a semiquantitative evaluation of 
ST3 mRNA expression [Figure 4(A)]. Densitometric scanning 
of the blots, after standardization for the total amount of 
mRNA deposited on the gel, indicated that in floating villi, 
the level of ST3 mRNA increased threefold from the first 
trimester to term [Figure 4(B)]. In contrast, the level of ST3 
mRNA measured in placental beds was 4.5-fold lower at term 
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In this study, the in vivo expression of ST3, a member of the 
MMP family, was analysed in human placenta during the first 
and third trimesters of gestation. To the best of our knowl- 
edge, this is the first demonstration of the spatiotemporal 
distribution of this enzyme during human pregnancy. 
The processes of implantation and placentation both depend 
on the penetration and remodelling of the uterine endo- 
metrium and vasculature by invasive trophoblasts. The migra- 
tory nature of human trophoblasts resembles closely that of 
highly invasive tumours, so that the normal trophoblasts have 
been called 'pseudomalignant' (Strickland and Richards, 1992). 
In the pregnant endometrium, the decidual cells surround 
themseh, es with a sparse fibrillar network of different matrix 
proteins, including laminin, fibronectin, collagens I, III, IV, V, 
entactin, heparan sulfate proteoglycan, etc. (Wewer et al., 
1985; Foidart et al., 1990; Damsky et al., 1992). To degrade 
these matrix components, human first trimester invasive 
trophoblasts have been shown to secrete a large array of 
proteolytic enzymes including u-PA (Hofmann et al., 1994), 
interstitial collagenase (Moll and Lane, 1990), gelatinase A
(Fernandez et al., 1992; Polette et al., 1994), gelatinase B
(Polette et al., 1994), and membrane-type MMP (Nawrocki 
et al., 1996). 
Immunohistochemical l belling and in situ hybridization 
showed that, in addition to these previously described pro- 
teinases, extravillous invasive trophoblasts also express ST3 
during the first and third trimesters of pregnancy. The level 
of ST3 expression was lower during the third trimester 
as revealed by Northern blot analysis. However, we can not 
completely exclude that this decreased ST3 mRNA level could 
result from a reduced number of IT present in term placental 
bed biopsies. 
Interestingly, CTB which proliferate to form TCC are in- 
















Figure 4. (A) Northern blot analysis of ST3 mRNA and 28 S rRNA in first 
and third trimester floating villi (FV) and placental beds (PB). Total RNA was 
isolated, elcctrophoresed and blot hybridized as described in 'Materials and 
.Methods'. Lanes 1, 2, 3: first trimester FV (9, 8, and 10 weeks, respectively); 
lanes 4, 5, 6: third trimester FV (38, 40, and 40 weeks, respectively); lanes 7, 
8, 9: first trimester PB (9, 8, and 10 weeks, respectively); lanes lfl, 11, 12: 
third-trimester PB (38, 41), and 40 weeks, respectively). (B)and (C) Densito- 
metric analysis of the Northern blot. Levels of ST3 transcripts in (B) floating 
villi and (C) placental beds of first and third trimesters were quantified by 
densitometric analysis of autoradiographs of the Northern blots. All rcsuhs 
were corrected for RNA loading by densitometric dataobtained for the 28 S 
rRNA signals. Results are expressed as optical density (OD) of ST3 
signal/OD of 28 S rRNA. Relative OD of individual samples (hatched bars) 
and mean values fi)r first and third trimesters (black bars) are presented. 
Gestation ages are identical to those described in (A). 
into highly invasive IT  (Damsky et al., 1992; Damsky, 
Sutherland and Fisher, 1993; Denker, 1993). They express 
ST3 only in their most distal regions, where they become 
embedded into the decidual compartment asIT. This spatially 
regulated onset of ST3 expression coincides with the down- 
regulation of the cc6134 integrin and the concomitant appearance 
of the cql31 integrin, which mediates the interaction of 
trophoblasts with different ECM ligands (Damsky et al., 1992; 
Damsky, Sutherland and Fisher, 1993). This switch in 
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adhesion-molecule expression has been shown to contribute to 
the acquisition of an invasive phenotype by cultured CTB 
(Damsky et al., 1992; Damsky, Sutherland and Fisher, 1993; 
Denker, 1993). Moreover, integrin-ligand interactions have 
been reported previously to modulate the expression of MMP 
in several cell lines (Werb et al., 1989; Seftor et al., 1993; 
Seltzer et al., 1994). Therefore, we hypothesize that during the 
differentiation of CTB into invasive IT, ST3 expression could 
be induced by specific integrin-mediated interactions with 
ECM components. Our observations indicate that the expres- 
sion of ST3 by these cells may contribute to the extensive 
basement membrane and stroma remodeling associated with 
first trimester trophoblast invasion. 
In addition to the extravillous trophoblasts, we also localized 
ST3 in the villous STB which line the intervillous vascular 
spaces. Previous studies demonstrated the presence of u-PA, 
interstitial collagenase, gelatinase A and B and their corre- 
sponding inhibitors (plasminogen-activator inhibitors 1 and 2 
and tissue inhibitor of metalloproteinase 1) in the villous STB 
(Feinberg et al., 1989; Moll and Lane, 1990; Fernandez et al., 
1992; Hofmann et al., 1994; Polette et al., 1994). In this 
particular location, it is possible that ST3, in conjunction with 
the other proteinases, may play a role by preventing extensive 
perivillous deposition of fibrin. Such deposits would reduce 
the solute transfer between the maternal and fetal blood, thus 
dangerously imiting the exchange of nutrients and gases to the 
embryo. 
It is interesting to note that the ST3 distribution pattern is 
very similar to that previously reported for u-PA (Hofmann 
ct al., 1994). These two proteinases are expressed mostly in the 
same trophoblastic cells (STB, IT and IVT), suggesting that 
both enzymes may cooperate during placenta formation and 
functioning, possibly through a proteinase cascade. A similar 
colocalization of these two proteinases has already been 
reported in breast carcinomas (Wolf et al., 1993), as well as 
during mouse embryo implantation (Lefebvre et al., 1995). 
Recently, Pei, Majmudar and Weiss (1994) demonstrated that 
purified human ST3 is able to cleave ct2-macroglobulin, an
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inhibitor of all proteinases, as well as two serine proteinase 
inhibitors: cq-proteinase inhibitor and the c~_,-antiplasmin. 
This demonstration reinforces the hypothesis that ST3 and 
u-PA could be involved in a proteolytic cascade. Indeed, 
cell-bound u-PA is a key enzyme in the initiation of the 
plasminogen activation cascade, a major pathway of extra- 
cellular proteolysis. Also, u-PA can convert he widely occur- 
ring zymogen plasminogen into enzymatically active plasmin 
(Dano et al., 1985; Liotta, Steeg and Stetler-Stevenson, 1991; 
P611~inen, Stephens and Vaheri, 1991), which can directly 
degrade various ECM glycoproteins (Montgomery et al., 1993) 
and activate other matrix-degrading enzymes, such as pro- 
interstitial collagenase (He et al., 1989; Murphy et al., 1994), 
pro-gelatinase B and pro-stromelysin-1 (Murphy et al., 1994) 
which mediate this matrix degradation. As ST3 is able to 
cleave and inactivate the proteinase inhibitors cited above, the 
concomitant production of ST3 and plasmin (via u-PA 
activity) by trophoblastic cells could be seen as a prerequisite 
for initiating a potent proteolytic cascade that enables the 
degradation of most ECM components. However, the capacity 
of other MMP to cleave plasmin inhibitors (Zhang et al., 1994; 
Noi~l et al., 1995) suggests that ST3 might also have another 
proteolytic activity against a more specific substrate, presently 
unknown (Noi~l et al., 1995). Our results also demonstrate hat, 
in contrast o epithelial tumor cells which induce the synthesis 
of ST3 in adjacent fibroblasts (Basset, Wolf and Chambon, 
1993), the invasive trophoblasts themselves produce ST3 and 
other proteinases which are involved in the infiltration of the 
maternal decidua. 
From these different observations, we can conclude that 
ST3 expression is spatially restricted to differentiated, non- 
proliferative, villous (STB) and extravillous (IT, PBGC and 
IVT) trophoblastic populations, both of which are involved in 
important steps of placentation. This demonstration consti- 
tutes the first non-fibroblastic localization to be reported for 
ST3. All previous tudies in human tissues indicated that ST3 
was exclusively expressed by stromal cells (for review, see 
Basset, Wolf and Chambon, 1993). 
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